Literature DB >> 24473490

An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.

Chelsea L Tasaka1, Cindy Burg, Sherilyn J VanOsdol, Lynne Bekeart, Andrew Anglemyer, Candy Tsourounis, Stephanie Rennke.   

Abstract

BACKGROUND: Overutilization of stress ulcer prophylaxis (SUP) in the intensive care unit (ICU) is common. Acid-suppressive therapies routinely used for SUP are best reserved for patients with greatest risk of clinically important bleeding as they have been associated with nosocomial pneumonia, Clostridium difficile infection and increased hospital cost.
OBJECTIVE: The primary objective was to reduce inappropriate utilization of SUP in 2 adult medical and surgical ICU settings at the University of California, San Francisco Medical Center. Secondary objectives included reduction of inappropriate continuation of SUP at ICU and hospital discharge.
METHODS: To attain the study objective, an interprofessional team developed a bundled quality improvement initiative, including an institution SUP guideline, pharmacist-led intervention, and an education and awareness campaign. To assess the impact of these interventions, we conducted a retrospective cohort study comparing data on prescribing practices at baseline before and after the intervention. Since computerized prescriber order entry (CPOE) was implemented during this time frame, preintervention data collection consisted of 2 periods, one before and one after CPOE implementation.
RESULTS: The incidence of the inappropriate use of SUP was not significantly different between the pre-CPOE and post-CPOE groups (20 and 19 per 100 patient-days, respectively; P = .88), but the incidence of inappropriate use of SUP was significantly lower in the postintervention group versus the post-CPOE group (9 and 19 per 100 patient-days, respectively; P = .03). At ICU discharge, 4% of patients in the post-intervention group were discharged inappropriately on SUP compared with 8% in the post-CPOE group (P = .54). At hospital discharge, none of the patients in the postintervention group were discharged inappropriately on SUP compared with 7% in the post-CPOE group (P = .22).
CONCLUSIONS: Implementation of an interprofessional bundled quality improvement initiative is effective in decreasing inappropriate use of SUP in adult medical and surgical ICUs at a university-affiliated, tertiary care academic medical center.

Entities:  

Keywords:  critical care; gastrointestinal prophylaxis; histamine-2 receptor antagonist; proton pump inhibitor; quality improvement; stress ulcer prophylaxis

Mesh:

Substances:

Year:  2014        PMID: 24473490     DOI: 10.1177/1060028013517088

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  12 in total

1.  Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients.

Authors:  Yeo Jin Choi; Joohyun Sim; Yun Tae Jung; Sooyoung Shin
Journal:  Br J Clin Pharmacol       Date:  2020-01-22       Impact factor: 4.335

2.  Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort Study.

Authors:  Christopher A Jones; Kevin D Betthauser; Bryan D Lizza; Paul A Juang; Scott T Micek; Marin H Kollef
Journal:  Hosp Pharm       Date:  2021-12-07

3.  Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.

Authors:  Vanessa Arriola; Jessica Tischendorf; Jackson Musuuza; Anna Barker; Jeffrey W Rozelle; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-28       Impact factor: 3.254

4.  Critical Care Pharmacists and Medication Management in an ICU Recovery Center.

Authors:  Joanna L Stollings; Sarah L Bloom; Li Wang; E Wesley Ely; James C Jackson; Carla M Sevin
Journal:  Ann Pharmacother       Date:  2018-02-18       Impact factor: 3.154

5.  Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.

Authors:  Sooyoung Shin
Journal:  Ther Clin Risk Manag       Date:  2015-05-24       Impact factor: 2.423

6.  Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis.

Authors:  Zhi-Kang Ye; Ying Liu; Xiang-Li Cui; Li-Hong Liu
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

7.  Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations.

Authors:  Hongli Luo; Qingze Fan; Shunlin Xiao; Kun Chen
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

8.  Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults.

Authors:  Drayton A Hammond; Catherine A Killingsworth; Jacob T Painter; Rose E Pennick; Kshitij Chatterjee; Bradley Boye; Nikhil Meena
Journal:  Pharm Pract (Granada)       Date:  2017-08-15

9.  A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.

Authors:  Umair Masood; Anuj Sharma; Zabeer Bhatti; Jessica Carroll; Amit Bhardwaj; Devamohan Sivalingam; Amit S Dhamoon
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

10.  Adherence to stress-related mucosal damage prophylaxis guideline in patients admitted to the Intensive Care Unit.

Authors:  Niloofar Rafinazari; Saeed Abbasi; Shadi Farsaei; Marjan Mansourian; Peyman Adibi
Journal:  J Res Pharm Pract       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.